Why tech transfer may be critical to beating COVID-19

<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
  <record>
    <leader>00000cam a22000004b 4500</leader>
    <controlfield tag="001">MAP20200026976</controlfield>
    <controlfield tag="003">MAP</controlfield>
    <controlfield tag="005">20220912143618.0</controlfield>
    <controlfield tag="008">180511e20200701usa||||       ||| ||eng d</controlfield>
    <datafield tag="040" ind1=" " ind2=" ">
      <subfield code="a">MAP</subfield>
      <subfield code="b">spa</subfield>
      <subfield code="d">MAP</subfield>
    </datafield>
    <datafield tag="084" ind1=" " ind2=" ">
      <subfield code="a">922.111</subfield>
    </datafield>
    <datafield tag="100" ind1="1" ind2=" ">
      <subfield code="0">MAPA20200017950</subfield>
      <subfield code="a">O'Sullivan, Cormac </subfield>
    </datafield>
    <datafield tag="245" ind1="1" ind2="4">
      <subfield code="a">Why tech transfer may be critical to beating COVID-19</subfield>
      <subfield code="c">Cormac O'Sullivan, Paul Rutten, Caspar Schatz</subfield>
    </datafield>
    <datafield tag="260" ind1=" " ind2=" ">
      <subfield code="a">New York</subfield>
      <subfield code="b">McKinsey & Company</subfield>
      <subfield code="c">2020</subfield>
    </datafield>
    <datafield tag="300" ind1=" " ind2=" ">
      <subfield code="a">8 p.</subfield>
    </datafield>
    <datafield tag="490" ind1="0" ind2=" ">
      <subfield code="a">Pharmaceuticals & Medical Products Practice</subfield>
    </datafield>
    <datafield tag="520" ind1=" " ind2=" ">
      <subfield code="a">Vaccines are considered to be our best chance for beating COVID-19, and many governments are counting on them to enable economic recovery. But to innoculate people worldwide as soon as vaccines are proven will require the pharmaceutical industry to ramp up quickly to unprecedented volumes of supply. The available global production capacity will be critical to that capability. And technology transfermoving the knowledge about and the ability to produce a vaccine from development to manufacturingwill determine how fast it happens. But tech transfer is as much a craft as a science. And it hasn't usually been on the critical path to production, so it comprises an underappreciated set of capabilities. To ensure adequate and timely supplies of COVID-19 vaccines and treatments, global institutions and pharma companies must collaborate to make tech transfer an industrialized, at-scale processbefore we need it.</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20200005599</subfield>
      <subfield code="a">COVID-19</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20200005391</subfield>
      <subfield code="a">Coronavirus</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080552022</subfield>
      <subfield code="a">Pandemias</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080556884</subfield>
      <subfield code="a">Vacunación</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080605674</subfield>
      <subfield code="a">Desarrollo tecnológico</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080606633</subfield>
      <subfield code="a">Industria farmacéutica</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080606787</subfield>
      <subfield code="a">Innovación empresarial</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080619749</subfield>
      <subfield code="a">Laboratorios farmacéuticos</subfield>
    </datafield>
    <datafield tag="700" ind1="1" ind2=" ">
      <subfield code="0">MAPA20200017967</subfield>
      <subfield code="a">Rutten, Paul </subfield>
    </datafield>
    <datafield tag="700" ind1="1" ind2=" ">
      <subfield code="0">MAPA20200017981</subfield>
      <subfield code="a">Schatz, Caspar </subfield>
    </datafield>
    <datafield tag="710" ind1="2" ind2=" ">
      <subfield code="0">MAPA20080442569</subfield>
      <subfield code="a">McKinsey & Company</subfield>
    </datafield>
    <datafield tag="830" ind1=" " ind2="0">
      <subfield code="0">MAPA20200017998</subfield>
      <subfield code="a">Pharmaceuticals & Medical Products Practice</subfield>
    </datafield>
  </record>
</collection>